Michigan Life Sciences and Innovation Center tenant Esperovax
Current Tenant


Esperovax is carrying out research and development on a novel method of delivering vaccinations orally. Vaccine injections must be administered by healthcare professionals, and needles may literally scare children and parents away. Esperovax hopes to become a global leader by developing oral tablets/capsules that can be more widely accessible, and could benefit remote populations that may not have access to typical healthcare providers.
Visit Esperovax Website